Data will never tell you how it feels to sit in that examination room hoping to hear that you’re not going to die. If you want to be great at pharma DTC marketing, stop reading this article for a minute, find a patient, and ask them about their story. Listen to them. Sure, your spreadsheet can tell you that patients aren’t filling their prescriptions, but your patients can tell you why. Afraid of the side effects? Confused about what the drug will actually do? Have to pay a $400 copay? Maybe your customer’s doctor gave them seven minutes of their time, and they didn’t feel like they knew what was going to happen next. Maybe they tried three other treatments that all failed. Who knows? But without hearing it straight from the horse’s mouth, you’ll never know. Or maybe the beautiful marketing message you crafted hit the mark.
Patient behavior isn’t always rational. It’s human.
Treating patients like consumers moving through the traditional purchase funnel is a huge mistake many make when executing on DTC marketing strategy. This isn’t how healthcare works. Patients are often frightened, embarrassed, frustrated, skeptical or exhausted. They’re trying to navigate physicians, insurers, pharmacies, prior authorization, side effects and misinformation online – often while feeling unwell from their disease.
That’s why empathy should be a core competency of your marketing team, not just a buzzword on your strategy deck. Read patient communities. Listen to patient advisory boards. Conduct qualitative interviews that aren’t just designed to validate your brand strategy. Listen to caregivers. Read the questions patients are asking their physicians and pharmacists. And when patients say something that flies in the face of your market research, don’t just explain it away. Get curious.
Stop asking only, “How do we get patients to ask for our drug?”
Ask better questions. What frightens patients about beginning treatment? What makes them quit? What are they confused about? What are they frustrated with when it comes to interacting with the healthcare system? What do they wish someone had told them six months ago? What would make them feel more comfortable speaking with their doctor? Those insights are worth far more than another dashboard.
The best DTC marketing may not feel like marketing
Sometimes the best thing a pharma marketer can do isn’t another TV ad or paid social campaign. It’s explaining the disease plainly. Helping patients prepare for the doctor’s appointment. Setting realistic expectations for treatment. Making financial assistance easy to understand. Explaining side effects without drowning them in medical jargon.
Helping somebody understand what happens after the prescription is filled. That’s patient-centered marketing. Empathy doesn’t mean manipulating patients’ emotions to get more prescriptions filled. It means understanding their experience well enough to provide helpful information and support that helps them make informed decisions with their healthcare providers.
Analytics still matter. Measurement still matters. ROI still matters. But the spreadsheet should inform what you learn from patients, not replace it. The best pharma DTC marketers know something incredibly simple: There’s a person behind every data point struggling to make a healthcare decision. Close your spreadsheet. Find that person. Listen.
And About Your Product Websites…
Online health seekers tend to approach pharmaceutical websites with a mixed mindset: they want authoritative information, but they know the company has something to sell. That tension is critical for DTC marketers.
Recent research helps frame the issue. In Pew Research Center’s 2026 survey, 60% of U.S. adults said they at least sometimes use major health websites such as WebMD or Mayo Clinic, while 85% at least sometimes get health information from healthcare providers. Among users of major health websites, 48% rated the information as very or extremely accurate. (Pew Research Center) Meanwhile, NIH guidance explicitly tells consumers to consider who owns a health website and whether its purpose is to inform or sell; it notes that commercial sites—including pharmaceutical-company sites—may contain useful information, but consumers can have difficulty separating education from promotion. (National Institute on Aging)
For pharma DTC marketers, I would think about the patient visiting a brand website as saying:
“I want your information, but I know you’re trying to sell me your drug.”
That changes how the website should be designed.
Patients are likely to evaluate a pharma site through several filters:
- “Are you giving me the whole story?” Patients increasingly know to look for balance, evidence, authorship, medical review and sources. MedlinePlus specifically recommends checking who created or reviewed health content and whether scientific references support it. (MedlinePlus)
- “Are you educating me or selling me?” NIH advises consumers to identify whether a site’s purpose is informational or commercial because sponsorship can influence how information is presented. (National Institute on Aging)
- “Does this answer the question I actually have?” Patients aren’t necessarily arriving thinking about “brand positioning.” They’re asking things like: Could this work for me? What are the side effects? How does it compare with what I’m taking? How much will it cost? What should I ask my doctor?
- “Can I trust you with my information?” Privacy matters, especially in healthcare. Current NIH guidance tells health-information seekers to understand what data a site collects and what it will do with that information before registering or providing personal details. (NCCIH)
- “Can I verify this somewhere else?” This is important. MedlinePlus actually advises people not to rely on a single website and to compare information across sources. (MedlinePlus) Pharma marketers should therefore assume that patients will—or at least should—cross-check claims.
What this means for pharma websites
The traditional DTC website often starts with the brand:
Drug → indication → benefits → safety → savings → ask your doctor.
I’d argue that an excellent patient website should start with the patient’s uncertainty:
My condition → my questions → my treatment choices → benefits and risks → what treatment might mean for me → cost/access → questions for my doctor → brand.
That’s a significant strategic difference. It also connects directly to your earlier point about getting pharma marketers out of spreadsheets and listening to patients. Analytics might show that 72% of visitors abandoned a page. They don’t tell you whether people left because they couldn’t find the answer they needed, didn’t understand the language, became frightened by something they read, distrusted the presentation, or simply got what they needed and left.
There’s another important data point: 58.5% of U.S. adults reported using the internet as a source of health information in the 2022 National Health Interview Survey. (NCCIH) Pharma isn’t just competing with other pharmaceutical websites for those people. It’s competing for credibility with physicians, Mayo Clinic, WebMD, government sources, patient communities, social media, AI and countless other information sources.
The competitive advantage for a pharma website therefore isn’t simply more content. It’s trust.
And trust is earned when patients feel the company is answering their questions rather than merely communicating messages.
Pharma marketers have a huge opportunity to improve patient marketing and make pharma companies a respected source of health information, but it won’t be easy. Stop referring to patients as “segments” and start looking at health from their point of view. We can get better.

